Last reviewed · How we verify

NCT04846413

Voice Analysis in Patients With Neurologic Diseases

Status unknown Last updated 22 March 2023
What this trial tests

trial testing Speech task in Voice Disorders in 100 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
31 July 2022
31 July 2023

Quick facts

Lead sponsorNeuromed IRCCS
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 September 2021
Primary completion31 July 2022
Estimated completion31 July 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Neuromed IRCCS

Who can join

Eligibility, any sex, with Voice Disorders or Neurologic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this observational pilot study, the investigators will record and assess voice samples from healthy participants and those participants affected by neurologic diseases to evaluate possible differences in voice features.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis.
    Suppa A, Asci F, Costantini G, Bove F, et al · · 2023 · cited 3× · PMID 37928137 · DOI 10.3389/fneur.2023.1267360

Verify or expand the search:

Other recruiting trials for Voice Disorders

Currently open trials in the same condition.

Other Neuromed IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04846413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing